GlassScriptPhysician profile
Juli A Smelser
NPI 1104075761
$6,959.74
in general payments reported to CMS, 2019-2025
40 companies · $2,074 in 2025
The $2,074 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,703 · 2022: $834 · 2023: $966 · 2024: $1,382 · 2025: $2,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,052 · Education: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,052.28 |
| Education | $370.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,044.32 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Medtronic, INC. | $810.45 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $562.54 | 2021-2025 | Dupixent |
| Harmony Biosciences LLC | $540.86 | 2023-2025 | Wakix |
| Glaxosmithkline, LLC. | $514.19 | 2021-2025 | Nucala, Arexvy, Trelegy Ellipta |
| United Therapeutics Corporation | $509.40 | 2021-2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.39 | 2022-2025 | Ofev, Jascayd |
| Amgen INC. | $267.73 | 2022-2025 | Tezspire |
| Axsome Therapeutics, INC. | $231.39 | 2022-2025 | Sunosi |
| Genzyme Corporation | $225.15 | 2023-2025 | |
| Abbvie INC. | $172.46 | 2021-2023 | |
| Insmed, INC. | $159.43 | 2022-2025 | Arikayce |
| Astellas Pharma US INC | $154.97 | 2021 | |
| Teleflex LLC | $131.64 | 2021 | |
| Endo Pharmaceuticals INC. | $128.15 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $110.73 | 2024 | Inspire |
| Jazz Pharmaceuticals INC. | $102.84 | 2022-2025 | |
| Myovant Sciences INC. | $96.42 | 2021 | |
| Mylan Specialty L.P. | $80.50 | 2023-2024 | Yupelri |
| Inogen, INC. | $78.60 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.48 | 2023-2025 | Glassia |
| Avadel Cns Pharmaceuticals, LLC | $63.87 | 2023-2025 | Lumryz |
| Bayer Healthcare Pharmaceuticals INC. | $59.47 | 2023-2025 | |
| Baxter Healthcare | $58.53 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $56.50 | 2024-2025 | Nuzyra |
| Blue Earth Diagnostics | $49.55 | 2021 | |
| Grifols USA, LLC | $44.42 | 2024-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $37.70 | 2021-2025 | Winrevair |
| Actelion Pharmaceuticals US, INC. | $36.10 | 2025 | Uptravi, Opsumit |
| Sunovion Pharmaceuticals INC. | $27.98 | 2021 | |
| Verona Pharma, INC. | $23.99 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $19.71 | 2025 | Yupelri |
| Fisher & Paykel Healthcare INC | $19.00 | 2024 | Fisher & Paykel Healthcare |
| Phadia US INC. | $18.86 | 2023 | Immunocap |
| Genentech USA, INC. | $18.21 | 2022 | |
| Axonics, INC. | $18.00 | 2021 | |
| Janssen Biotech, INC. | $17.82 | 2021 | |
| Clovis Oncology, INC. | $16.88 | 2021 | |
| Electromed, INC. | $12.35 | 2022 | |
| Dentsply Ih Ab | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juli Smelser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.